Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Cell Viability Assays Market Growth Performance Trended Historically, And What Lies Ahead?

The scale of the cell viability assays market has expanded swiftly in recent times, increasing from $1.56 billion in 2024 to anticipated $1.73 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.8%. Factors contributing to this surge during the historic period include heightened funding for cancer studies, escalating spendings on pharmaceutical research & development, enlargement of the biotechnology sector, acceleration in progress in cell culture techniques, surge in stem cell research demand, growing necessity for toxicity testing, elevated use of real-time cell analysis systems, and an increase in the amount of contract research organizations (CROs).

What Is the Forecast for the Cell Viability Assays Market Size Through 2029?

The foreseeable advancement in the market size of cell viability assays is impressive, with anticipated growth hitting $2.58 billion by 2029, reflecting a compound annual growth rate (CAGR) of 10.5%. This expected increase within the forecasted period is due to the increased need for personalized healthcare, enhanced government support for cell-based studies, a more significant focus on precision medicine and stem cell research, and more accessible automated cell viability analyzers. A surge in the spread of infectious diseases, efforts towards boosting the precision and sensitivity of assays, better understanding of cell viability assays benefits, increasing development of organ-on-a-chip technologies, as well as heightened demand for regenerative medicine are other contributing factors. The forecast period also indicates trends such as improvements in high throughput screening, incorporation of artificial intelligence and machine learning, real-time monitoring systems development, application of automated fluid management systems, progression in the creation of multiplex assays for simultaneous cell viability measurement, usage of sustainable, environmentally friendly reagents, user-friendly assay kits development, advancements in electrochemical assays, scalable cell viability assays integration, as well as the development of assays that are compatible with primary and stem cells.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

What are the Key Market Players in Cell Viability Assays Market and How They’re Evolving?

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

What Are the Primary Growth Drivers in the Cell Viability Assays Market?

The surge in cell-based therapeutics is anticipated to boost the expansion of the cell viability assay market. Cell-based therapeutics involve treatments deploying living cells to mend or substitute damaged tissues, address diseases, or reestablish usual functioning. The escalation in cell-based therapeutics owes to breakthroughs in biotechnology, rising investment in regenerative medicine, a broadening acceptance and implementation of cell therapies, coupled with enhancement in cell engineering and manufacturing technologies. This therapeutics gains from cell viability assays by maintaining the well-being, functionality, and security of therapeutic cells, consequently amplifying treatment efficacy and quality control. For example, according to the American Society of Gene & Cell Therapy, a non-profit medical and scientific organization located in the US, they commenced 38 trials for non-genetically modified cell therapies in Q1 2023, an increase of 7 from the prior quarter, Q4 2022. Thus, the growing trend of cell-based therapeutics is influencing the growth of the cell viability assay market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp

What Are the Leading Segments in the Global Cell Viability Assays Industry?

The cell viability assays market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications

3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates

2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

What Are the Key Market Trends in the Cell Viability Assays Industry?

Leading organizations in the cell viability assays marketplace are engineering advanced cell screening procedures to enhance precision and expedite the drug discovery process. These cell screening techniques amplify the effectiveness of cell viability assays through their ability to perform a quick, detailed, and high-volume investigation of cell health and reactions. This optimizes experimental circumstances and advances the formulation of therapeutic methodologies. For example, in May 2024, Arralyze, a tech firm based in Germany, launched CellShepherd, a ground-breaking platform for single-cell examination. It leverages unique nanowell glass arrays for shrinking cell-based assays, facilitating real-time observation. The self-sufficient system provides exact cell dispensing, co-culturing under sterile conditions, and imaging using brightfield and fluorescent channels. The AI-fueled analysis ensures precise cell counting and tracing, making it a user-friendly platform that meets the growing demand for accurate single-cell studies in the biomedical and life science sectors.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

What Is the Regional Outlook for the Cell Viability Assays Market?

North America was the largest region in the cell viability assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16014

This Report Delivers Insight On:

1. How big is the cell viability assays market, and how is it changing globally?

2. Who are the major companies in the cell viability assays market, and how are they performing?

3. What are the key opportunities and risks in the cell viability assays market right now?

4. Which products or customer segments are growing the most in the cell viability assays market?

5. What factors are helping or slowing down the growth of the cell viability assays market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model